{
  "trial_id": "NCT03740906",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "voluntarily signed informed consent form",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "age \u226518 years on day of signing informed consent form",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "chronic HCV infection",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "recent injecting drug use (within the previous 6 months)",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "eligible for DAA therapy as per the PBS",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "unable or unwilling to provide informed consent or abide by the requirements of the study",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "alcoholic liver disease",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient has chronic HCV infection and is eligible for DAA therapy. However, he has a history of recent coinfection with HBV which may be relevant to his treatment plan.",
  "_meta": {
    "topic_id": "64",
    "trial_id": "NCT03740906",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}